pharma news today glp-1 obesity drug Eli Lilly pill Foundayo gets the FDA green light : NPR The Multi-Sector Impacts of GLP-1RA

Osteoporosis is a disease that causes bones to become brittle and easily break, and postmenopausal women are at particularly higher risk of the disease

BPC-157 is a synthetic peptide that has been investigated in preclinical research for tissue repair and anti-inflammatory effects, but it is not approved as a medicine by major regulatory agencies, and evidence from human clinical trials remains limited

doi: 10.1111/j.1463-1326.2010.01337.x

Reconstituted vials: refrigerate and use within 28 days Once mixed with bacteriostatic water, keep the vial refrigerated and away from direct light

High glucose-induced changes in hyaloid-retinal vessels during early ocular development of zebrafish: a short-term animal model of diabetic retinopathy